Stem cell treatment for diabetes is indicated in all stages of the disease. However, it is the most effective in cases of:
New-onset insulin-dependent diabetes mellitus;
Diabetes mellitus complicated by diabetic glomerulosclerosis, chronic renal failure (grade 1 and 2) and anemic syndrome;
Laboratory course of diabetes mellitus;
Diabetes mellitus associated with complications of infection and immunodeficiency;
Presence of trophic ulcers resistant to soft tissue treatments;
Resistance secondary to sulfanilamide and the need for patients with type II diabetes mellitus to be transferred to insulin therapy.
After stem cell therapy, patients with diabetes mellitus report standardization of immunological and hematological indices, reduction of micro and macroangiopathy manifestations and trophic alterations, restoration of workability. In case of treatment, the progression of the disease is hampered, and the periods of remission become 2-3 times longer. The severity and frequency of diabetes complications decrease. The quality of life and the average life expectancy increase.
For more information visit
Video credits to Dr. Pradeep Mahajan YouTube channel